- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-22-0001601

About Virdev Intermediates Private Limited
Data last updated:
Virdev Intermediates Private Limited is a private limited company based in Surat, Gujarat, India, a subsidiary of Bdr Pharmaceuticals International Private Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 01 February 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ1994PTC021189. Its GSTIN is 24AAACV8038L1Z2 (Gujarat).
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹5.41 Cr. It is led by directors including Kaushik Bhagwandas Jariwala and Narendra Bhagwandas Jariwala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S No 33/1 – A Plot No – 1 Khatodara B/H Sub Jail Surat, Gujarat, India – 395002.
As per the financials filed for FY 2025, the company reported a revenue of ₹107.72 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹8.71 Cr (net margin 8.1%) and EBITDA of ₹16.95 Cr (EBITDA margin 15.7%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 21% over five years.
The company has about 334 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: BDR Pharmaceuticals Internationals. As per MCA filings, the company has satisfied charges of ₹92.47 Cr on record. Court records list 18 cases involving the company, including 4 filed by the company and 14 filed against it; 3 cases are pending. The company has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹20.12 Cr; the latest was in July 2018. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Bakul Pharma Private Limited with revenue of ₹110.31 Cr. The company has 20 MSME Form 1 returns on record between 2015 and 2023, listing 2,196 overdue payments to 156 micro and small suppliers.
Virdev Intermediates Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-22-0001601). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bdrpharma.com.
Company details
Recognitions & Rankings of Virdev Intermediates
Contact details
Virdev Intermediates Private Limited's registered office is in Surat, Gujarat. Its website is bdrpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressS No 33/1 – A Plot No – 1 Khatodara B/H Sub Jail Surat, Gujarat, India – 395002
- IndustryPharma, API Manufacturers
To see the full contact details of Virdev Intermediates Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Virdev Intermediates operates one associated brand: BDR Pharmaceuticals Internationals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| APIs and finished products are developed and manufactured. | bdrpharma.com |
Business activity
The main business activity of Virdev Intermediates is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Virdev Intermediates Private Limited, buy the company report.
Financials of Virdev Intermediates Private Limited
FY 2025 filings availableVirdev Intermediates Private Limited reported revenue of ₹107.72 Cr (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 21%. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.95 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.71 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.7% | ||||
| Net Profit Margin | 8.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Virdev Intermediates Private Limited, buy the company report.
Board of directors of Virdev Intermediates Private Limited
Virdev Intermediates has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kaushik Bhagwandas Jariwala Also directs: Banco Organic LLP | Director | 12 Nov 2000 | 25 Years 11 Months | Current |
| Narendra Bhagwandas Jariwala Also directs: The Surat Art Silk Cloth Manufacturers Association | Director | 01 Feb 1994 | 32 Years 9 Months | Current |
| Sanjay Amritlal Solanki Also directs: Nimbasia Stabilizers LLP, Peekay Synthetics Private Limited, Sunshine Organics Pvt Ltd and 1 more | Director | 12 Nov 2000 | 25 Years 11 Months | Current |
| Viralkumar Narendrabhai Jariwala | Director | 12 Nov 2000 | 25 Years 11 Months | Current |
| Dheer Dharmesh Shah Also directs: BDR Lifesciences Private Limited, Spinos Life Science and Research Private Limited, BNJ Innovations LLP and 3 more | Director | 01 Mar 2024 | 2 Years 8 Months | Current |
| Raheel Dharmesh Shah Also directs: Sunshine Organics Pvt Ltd, BDR Lifesciences Private Limited, BDR Pharmaceuticals International Private Limited and 3 more | Director | 27 Jul 2018 | 8 Years 3 Months | Current |
Peer comparison
Virdev Intermediates Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bakul Pharma Private Limited | ₹110.31 Cr (FY 2025) | -21.0% | Mumbai, Maharashtra, India | |||
| Danopharm Private Limited | ₹108.78 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Almelo Private Limited | ₹108.05 Cr (FY 2024) | 22.0% | Hyderabad, Telangana, India | |||
| Virdev Intermediates Private Limitedthis company | ₹107.72 Cr (FY 2025) | ₹8.71 Cr | 8.1% | -3.0% | 334 | Surat, Gujarat, India |
| Panchsheel Organics Limited | ₹107.68 Cr (FY 2024) | 3.0% | Indore, Madhya Pradesh, India | |||
| Patel Chem Specialities Limited | ₹105.55 Cr (FY 2025) | 28.0% | Ahmedabad, Gujarat, India | |||
| Lucent Drugs Private Limited | ₹104.13 Cr (FY 2025) | 101.0% | Sanathnagar, Telangana, India | |||
| Novo Excipients Private Limited | ₹103.54 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India | |||
| Par Active Technologies Private Limited | ₹103.46 Cr (FY 2025) | 2.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Virdev Intermediates Private Limited, buy the company report.
Auditor
Virdev Intermediates Private Limited is audited by M. R. BOMBAYWALA & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M. R. BOMBAYWALA & CO. | FY 2022 | 123117W |
Shareholding
The shareholding of Virdev Intermediates Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Virdev Intermediates Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Mar 2015 | 10569075 | Kotak Mahindra Bank Limited | ₹4.9 Cr | Satisfied | |
| 31 Jul 2014 | 10515182 | Kotak Mahindra Bank Limited | ₹18.19 Cr | Satisfied | |
| 18 Jul 2014 | 10516190 | Ing Vysya Bank Limited | ₹16.06 Cr | Satisfied | |
| 30 Jul 2013 | 10449122 | Central Bank of India | ₹1.9 Cr | Satisfied | |
| 23 Mar 2007 | 10048117 | Central Bank of India | ₹12 Cr | Satisfied |
To see the full charge records of Virdev Intermediates Private Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
Virdev Intermediates Private Limited has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹20.12 Cr; the latest was in July 2018.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2018 | Funding round | ₹17.62 Cr | Investors: BDR Pharmaceuticals International Private Limited |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Aug 2014 | Funding round | ₹1.5 Cr | Investors: 4 individuals |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Rikhabji Corporation, 2 individuals |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
To see the full deal history of Virdev Intermediates Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Virdev Intermediates Private Limited has 18 court cases on record: 4 filed by Virdev Intermediates, 14 filed against it. 3 cases are pending and 15 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 11 | 9 | 0 |
| District courts | 4 | 3 | 0 |
| Supreme Court | 3 | 2 | 3 |
Cases on record (5 of 18)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (1801-Ordinary Civil Matters : T.P. Under Article 139A(1) of the Constitution of India) | Filed by the company against Emcure Pharmaceuticals Ltd. THR. Director Emcure House, T 184, M.I.D.C. Bhosari Pune, Maharashtra 411026 , , Other and 2 others | Pending |
| Bombay High Court | Court case (NMCD) | Filed against the company by Symed Labs Ltd. | Disposed |
| Bombay High Court | Criminal complaint | Filed against the company by Symed Labs Ltd. | Disposed |
| Bombay High Court | Court case (COMIP) | Filed against the company by Symed Labs Ltd. | Disposed |
| Bombay High Court | Court case (S) | Filed against the company by Navdeep Chemicals Pvt. Ltd. | Disposed |
To see the full case history of Virdev Intermediates Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Virdev Intermediates Private Limited was last rated by Care on 30 Nov 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 30 Nov 2021 |
To see the full credit ratings and regulatory alerts of Virdev Intermediates Private Limited, buy the company report.
MSME payment delays
Virdev Intermediates Private Limited has 20 MSME Form 1 returns on record between 2015 and 2023, listing 2,196 overdue payments to 156 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 156)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Amar Dresses | |||
| Surat Ammonia and Chemical Company | |||
| an individual supplier | |||
| Uni-Tech Valves & Automation |
To see the full MSME payment records of Virdev Intermediates Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Virdev Intermediates Private Limited has a workforce of 334 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 334 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Virdev Intermediates Private Limited, buy the company report.
GST
Virdev Intermediates has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACV8038L1Z2 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Virdev Intermediates Private Limited, buy the company report.
Recent activity
Virdev Intermediates Private Limited has 9 board changes on record since 1994: 6 appointments and 3 cessations. The latest: Dheer Dharmesh Shah ceased to be Additional Director on 26 Sep 2024.
24 earlier events are in the company report.
News
Frequently asked questions
Virdev Intermediates is an active private limited company based in Surat, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 01 February 1994 (32+ years old) and is registered under CIN U24230GJ1994PTC021189.
Virdev Intermediates has 6 current directors:
- Kaushik Bhagwandas Jariwala - Director
- Narendra Bhagwandas Jariwala - Director
- Sanjay Amritlal Solanki - Director
- Viralkumar Narendrabhai Jariwala - Director
- Dheer Dharmesh Shah - Director
- Raheel Dharmesh Shah - Director
The latest financial statements of Virdev Intermediates on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Virdev Intermediates is 24AAACV8038L1Z2, registered in Gujarat.
The CIN (Corporate Identification Number) of Virdev Intermediates is U24230GJ1994PTC021189. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Virdev Intermediates has 18 court cases on record: 4 filed by the company and 14 filed against it. 3 are pending. Most are in the high courts.
Virdev Intermediates was incorporated on 01 February 1994, making it 32+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Virdev Intermediates has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹20.12 Cr; the latest was in July 2018.
The peers of Virdev Intermediates by revenue are Bakul Pharma Private Limited, Danopharm Private Limited, Almelo Private Limited, Panchsheel Organics Limited, Patel Chem Specialities Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dheer Dharmesh Shah ceased to be Additional Director on 26 Sep 2024. Dheer Dharmesh Shah was appointed as Director on 01 Mar 2024. Raheel Dharmesh Shah ceased to be Additional Director on 29 Sep 2018. Virdev Intermediates has 9 board changes on record in total.
Yes, Virdev Intermediates is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-22-0001601).
Virdev Intermediates has 20 MSME Form 1 returns on record between 2015 and 2023, listing 2,196 overdue payments to 156 micro and small suppliers. The latest return was filed on 06 Nov 2023.

